Nebula Biocides GmbH, the latest spin-off from the Leibniz Institute for Plasma Science and Technology (INP) in Greifswald, is one of two recipients of this year’s Leibniz Start-up Award. Founders Dr. Jörn Winter, Dr. Ansgar Schmidt-Bleker, and Prof. Klaus-Dieter Weltmann received the happy news directly from the Leibniz headquarters in Berlin. The award is endowed with a total of 50,000 euros and is presented annually by the Leibniz Association to start-up projects that distinguish themselves through outstanding achievements in the development of innovative and sustainable business ideas.
“We are, of course, very pleased about this recognition. The award highlights the great importance that effective hygiene must have in our society today, and encourages us to continue pursuing our path towards effective protection against pathogens,” said Dr. Jörn Winter, one of the managing directors of Nebula Biocides GmbH.
Since 2016, the scientists have been researching a highly effective disinfectant agent which, within just 30 seconds, is effective against both stubborn bacterial spores and resilient viruses. In particular, it can completely inactivate Clostridioides difficile spores. Broad use of this new disinfection method could significantly reduce infection risks, for example in hospitals.
After three years of intensive research, in 2019 the scientists took the plunge and founded Nebula Biocides GmbH. “The efficacy, fundamental compatibility, and safety of the process have already been confirmed in accredited laboratories. Now all that remains is the official approval, which we are now working towards intensively together with our partners and, of course, the regulatory authorities,” explained Dr. Ansgar Schmidt-Bleker, the second managing director. “This award naturally gives us a motivational boost in this situation.”
Although the formal award ceremony will not take place until November in Berlin due to the current situation, Prof. Klaus-Dieter Weltmann, Chairman of the Board and Scientific Director of INP, is already delighted along with the two scientists. “This is a great achievement for Nebula Biocides GmbH and, of course, also especially for our institute. It demonstrates that our strategy at INP of ‘from idea to prototype’ is working,” said Prof. Klaus-Dieter Weltmann.
Through spin-offs, the INP has now successfully completed technology transfers for the fifth time.
Für weitere Informationen:
Nebula Biocides GmbH
Dr. Jörn Winter
Brandteichstraße 20
17489 Greifswald
E-Mail: winter@nebula-biocides.de
Tel.: +49 (0)159 / 04283902
www.nebula-biocides.de
Dr. Gesine Selig
Referat Kommunikation
Tel.: +49 3834 554 3942
gesine.selig@inp-greifswald.de
